p.82 抽出テキスト

CLINICAL STATEMENTS AND GUIDELINES

August 29, 2023 Circulation. 2023;148:e9–e119. DOI: 10.1161/CIR.0000000000001168

Virani et al 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Chronic Coronary Disease Guideline

29.	 Freij M, Dullabh P, Lewis S, et al. Incorporating social determinants of health in electronic health records: qualitative study of current practices among top vendors. JMIR Med Inform. 2019;7:e13849. 30.	 Magnan S. Social determinants of health 201 for health care: plan, do, study, act. NAM Perspect. 2021;2021:1. doi: 0.31478/202106c 31.	 Meyer D, Lerner E, Phillips A, et al. Universal screening of social determinants of health at a large US academic medical center. Am J Public Health. 2020;110:S219–S221. 32.	 Adler NE, Stead WW. Patients in context: EHR capture of social and behavioral determinants of health. N Engl J Med. 2015;372:698–701. 33.	 Gajardo AI, Henriquez F, Llancaqueo M. Big data, social determinants of coronary heart disease and barriers for data access. Eur J Prev Cardiol. 2020;2047487320922366. 34.	 Berman AN, Biery DW, Ginder C, et al. Association of socioeconomic disadvantage with long-term mortality after myocardial infarction: the Mass General Brigham YOUNG-MI Registry. JAMA Cardiol. 2021;6:880–888. 35.	 Shaw LJ, Merz CN, Bittner V, et al. Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Womens Health (Larchmt). 2008;17:1081–1092. 36.	 Kelli HM, Mehta A, Tahhan AS, et al. Low educational attainment is a predictor of adverse outcomes in patients with coronary artery disease. J Am Heart Assoc. 2019;8:e013165. 37.	 Wadhera RK, Bhatt DL, Kind AJH, et al. Association of outpatient practicelevel socioeconomic disadvantage with quality of care and outcomes among older adults with coronary artery disease: implications for value-based payment. Circ Cardiovasc Qual Outcomes. 2020;13:e005977. 38.	 Mehta RH, O'Shea JC, Stebbins AL, et al. Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis. J Am Coll Cardiol. 2011;57:138–146. 39.	 Gerber Y, Goldbourt U, Drory Y. Interaction between income and education in predicting long-term survival after acute myocardial infarction. Eur J Cardiovasc Prev Rehabil. 2008;15:526–532. 40.	 Mathews L, Brewer LC. A review of disparities in cardiac rehabilitation: evidence, drivers and solutions. J Cardiopulm Rehabil Prev. 2021;41:375–382. 41.	 Lemstra ME, Alsabbagh W, Rajakumar RJ, et al. Neighbourhood income and cardiac rehabilitation access as determinants of nonattendance and noncompletion. Can J Cardiol. 2013;29:1599–1603. 42.	 Udell JA, Desai NR, Li S, et al. Neighborhood socioeconomic disadvantage and care after myocardial infarction in the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes. 2018;11:e004054. 43.	 South EC, Hohl BC, Kondo MC, et al. Effect of greening vacant land on mental health of community-dwelling adults: a cluster randomized trial. JAMA Netw Open. 2018;1:e180298. 44.	 Dubowitz T, Zenk SN, Ghosh-Dastidar B, et al. Healthy food access for urban food desert residents: examination of the food environment, food purchasing practices, diet and BMI. Public Health Nutr. 2015;18:2220–2230. 45.	 Creatore MI, Glazier RH, Moineddin R, et al. Association of neighborhood walkability with change in overweight, obesity, and diabetes. JAMA. 2016;315:2211–2220. 46.	 Powell-Wiley TM, Moore K, Allen N, et al. Associations of neighborhood crime and safety and with changes in body mass index and waist circumference: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2017;186:280–288. 47.	 Remigio-Baker RA, Diez Roux AV, Szklo M, et al. Physical environment may modify the association between depressive symptoms and change in waist circumference: the multi-ethnic study of atherosclerosis. Psychosomatics. 2014;55:144–154. 48.	 Rutledge T, Reis SE, Olson M, et al. Social networks are associated with lower mortality rates among women with suspected coronary disease: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation study. Psychosom Med. 2004;66:882–888. 49.	 Brewer LC, Fortuna KL, Jones C, et al. Back to the future: achieving health equity through health informatics and digital health. JMIR Mhealth Uhealth. 2020;8:e14512. 50.	 Shah LM, Ding J, Spaulding EM, et al. Sociodemographic characteristics predicting digital health intervention use after acute myocardial infarction. J Cardiovasc Transl Res. 2021;14:951–961. 51.	 Bhardwaj V, Spaulding EM, Marvel FA, et al. Cost-effectiveness of a digital health intervention for acute myocardial infarction recovery. Med Care. 2021;59:1023–1030. 52.	 O'Brien KH. Social determinants of health: the how, who, and where

screenings are occurring; a systematic review. Soc Work Health Care. 2019;58:719–745. 53 Samuels-Kalow ME, Boggs KM, Cash RE, et al. Screening for health-

related social needs of emergency department patients. Ann Emerg Med. 2021;77:62–68. 54.	 Kangovi S, Mitra N, Norton L, et al. Effect of community health worker support on clinical outcomes of low-income patients across primary care facilities: a randomized clinical trial. JAMA Internal Medicine. 2018;178:1635–1643. 55.	 American Hospital Association. A Playbook for Fostering Hospital-commu-

nity Partnerships to Build a Culture of Health. 2017. Accessed June 30, 2021. https://www.aha.org/system/files/hpoe/Reports-HPOE/2017/Aplaybook-forfostering-hospitalcommunity-partnerships.pdf. 4.2.1. Nutrition, Including Supplements 1.	 Rees K, Takeda A, Martin N, et al. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease. Cochrane Database Sys Review. 2019;3:CD009825. 2.	 de Lorgeril M, Salen P, Martin JL, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99:779– 785. 3.	 Li S, Chiuve SE, Flint A, et al. Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med. 2013;173:1808– 1818. 4.	 Sawicki CM, Jacques PF, Lichtenstein AH, et al. Whole- and refined-grain consumption and longitudinal changes in cardiometabolic risk factors in the Framingham offspring cohort. J Nutr. 2021;151:2790–2799. 5.	 Threapleton DE, Greenwood DC, Evans CEL, et al. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2013;347:f6879. 6.	 Hooper L, Martin N, Jimoh OF, et al. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2020;5:CD011737. 7.	 O'Donnell MJ, Yusuf S, Mente A, et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA. 2011;306:2229–2238. 8.	 Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3–10. 9.	 Guasch-Ferre M, Babio N, Martinez-Gonzalez MA, et al. Dietary fat intake and risk of cardiovascular disease and all-cause mortality in a population at high risk of cardiovascular disease. Am J Clin Nutr. 2015;102:1563–1573. 10.	 Kiage JN, Merrill PD, Robinson CJ, et al. Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort. Am J Clin Nutr. 2013;97:1121–1128. 11.	 Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2020;3:CD003177. 12.	 Schwingshackl L, Boeing H, Stelmach-Mardas M, et al. Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a systematic review and meta-analysis of primary prevention trials. Adv Nutr. 2017;8:27–39. 13.	 Bosch J, Gerstein HC, Dagenais GR, et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med. 2012;367:309–318. 14.	 Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007;115:846–854. 15.	 Barbarawi M, Kheiri B, Zayed Y, et al. Vitamin D supplementation and cardiovascular disease risks in more than 83 000 individuals in 21 randomized clinical trials: a meta-analysis. JAMA Cardiology. 2019;4:765–776. 16.	 Zhang Y, Fang F, Tang J, et al. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ. 2019;366:l4673. 17.	 Yusuf S, Dagenais G, et al.; Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in highrisk patients. N Engl J Med. 2000;342:154–160. 18.	 Kim J, Choi J, Kwon SY, et al. Association of multivitamin and mineral supplementation and risk of cardiovascular disease: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2018;11:e004224. 19.	 Cook NR, Albert CM, Gaziano JM, et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the women's antioxidant cardiovascular study. Arch Intern Med. 2007;167:1610–1618. 20.	 Wang X, Chen H, Ouyang Y, et al. Dietary calcium intake and mortality risk from cardiovascular disease and all causes: a meta-analysis of prospective cohort studies. BMC Med. 2014;12:158. 21.	 Myung S-K, Kim H-B, Lee Y-J, et al. Calcium supplements and risk of cardio-

vascular disease: a meta-analysis of clinical trials. Nutrients. 2021;13:368.

Downloaded from http://ahajournals.org by on October 7, 2026